Medications

Scientists discover how remdesivir works to inhibit coronavirus

More effective antiviral treatments could be on the way after research from The University of Texas at Austin sheds new light on the COVID-19 antiviral drug remdesivir, the only treatment of its kind currently approved in ...

Medications

New COVID-19 treatment trial results published

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to ...

Medical research

Why remdesivir does not fully stop the coronavirus

Remdesivir is the first drug against COVID-19 to be conditionally approved in Europe and the United States. The drug is designed to suppress the rapid replication of the SARS-CoV-2 virus in human cells by blocking the viral ...

Medications

Researcher urges caution using remdesivir to treat COVID-19

While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its ...

Diseases, Conditions, Syndromes

Remdesivir likely to be highly effective antiviral against SARS-CoV-2

The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists. Writing in Nature Communications, the researchers describe giving the drug to a patient ...

Medications

Baricitinib plus remdesivir shows promise for treating COVID-19

The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal ...

Diseases, Conditions, Syndromes

FDA issues EUA to baricitinib plus remdesivir for COVID-19

(HealthDay)—Emergency use authorization was issued for baricitinib in combination with remdesivir for hospitalized patients with COVID-19, the U.S. Food and Drug Administration announced Thursday.

page 1 from 6